GSK343
- 1 lab in 1 country
- Funders: Colorado Clinical & Translational Sciences Institute and 1 more
- Cells1
Outcomes
4Primary chondrocyte proliferation
upin human cells1
1 study
Primary chondrocyte proliferation
upin human cells1
GSK343 increases primary chondrocyte proliferation in human cells.
“Functionally, conditioned media from GSK343-treated MSCs significantly increased primary chondrocyte proliferation, demonstrating preserved therapeutic potency.”
Cellsconditioned media from GSK343-treated MSCs
bioRxiv : the preprint server for biology12 Dec 2025Preprint
Cellular senescence
downin human cells1
1 study
Cellular senescence
downin human cells1
GSK343 inhibits cellular senescence in human cells.
“RNA-seq demonstrated that GSK343 maintained transcriptional programs associated with immunomodulation, migration, and trophic signaling, while suppressing hyperproliferative and senescence-associated genes that are characteristic of late-passage MSCs.”
Cellsin late-passage MSCs
bioRxiv : the preprint server for biology12 Dec 2025Preprint
Stem cell maintenance
upin human cells1
1 study
Stem cell maintenance
upin human cells1
GSK343 improves stem cell maintenance in human cells.
“Pharmacological inhibition of EZH2 with GSK343 selectively reduced H3K27me3, restored ARID1A-containing SWI/SNF organization, and preserved MSC morphology and expression of canonical stemness markers (CD73, CD90, CD105) even at later passage.”
Cellsat later passage during expansion
bioRxiv : the preprint server for biology12 Dec 2025Preprint
H3K27me3
downin human cells1
1 study
H3K27me3
downin human cells1
GSK343 decreases H3K27me3 in human cells.
“Pharmacological inhibition of EZH2 with GSK343 selectively reduced H3K27me3, restored ARID1A-containing SWI/SNF organization, and preserved MSC morphology and expression of canonical stemness markers (CD73, CD90, CD105) even at later passage.”
Cellsin-vitro expansion on standard tissue-culture plastic
bioRxiv : the preprint server for biology12 Dec 2025Preprint